• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首发精神病复发预防的随机对照试验中复发测量的系统评价。

A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis.

机构信息

Psychological Sciences, The University of Melbourne, University of Melbourne Psychology Clinic, The University of Melbourne, Victoria, Australia.

出版信息

Schizophr Res. 2010 Jun;119(1-3):79-88. doi: 10.1016/j.schres.2010.02.1073. Epub 2010 Mar 29.

DOI:10.1016/j.schres.2010.02.1073
PMID:20347266
Abstract

The prevention of relapse is an important treatment goal in first-episode psychosis. Randomized controlled trials (RCTs) provide the gold standard methodology for evaluating interventions for relapse prevention. Properly designed RCTs which include relapse as a treatment outcome should rigorously operationalize psychotic relapse. The aim of this systematic literature review was to evaluate according to six criteria the operationalization of relapse in RCTs of clinical innovations for the prevention of relapse in first-episode psychosis. Through a systematic literature search of relevant RCTs in first-episode psychosis patients, eight pharmacological and eight non-pharmacological trials, published between 1982 and 2009, were identified. Readmission to a psychiatric hospital was the most common definition of psychotic relapse. Five studies did not measure relapse using any standardized or validated observer-rated instruments. The majority of the studies did not specify a duration criterion for relapse. Only three studies satisfied six criteria for the adequate operationalization of relapse. These results raise concerns regarding the internal and external validity of these research findings. There is an urgent need for a standardized, universally adopted set of criteria for psychotic relapse with appropriate specification of measurement instruments for use in future RCTs.

摘要

预防复发是首发精神病治疗的一个重要目标。随机对照试验(RCT)为评估预防复发的干预措施提供了金标准方法。适当设计的 RCT 应将复发作为治疗结果纳入,严格对精神病复发进行操作化定义。本系统文献回顾旨在根据六个标准评估首发精神病预防复发的临床创新 RCT 中复发的操作化定义。通过对首发精神病患者相关 RCT 的系统文献检索,共确定了 8 项药理学和 8 项非药理学试验,这些试验发表于 1982 年至 2009 年之间。精神病复发的最常见定义是重新入院精神病院。五项研究未使用任何标准化或经过验证的观察者评定工具来测量复发。大多数研究没有规定复发的持续时间标准。只有三项研究满足了充分操作化复发的六个标准。这些结果引起了对这些研究结果的内部和外部有效性的关注。目前迫切需要一套标准化的、普遍采用的精神病复发标准,以及用于未来 RCT 的适当测量工具规范。

相似文献

1
A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis.首发精神病复发预防的随机对照试验中复发测量的系统评价。
Schizophr Res. 2010 Jun;119(1-3):79-88. doi: 10.1016/j.schres.2010.02.1073. Epub 2010 Mar 29.
2
Early intervention for psychosis.精神病的早期干预
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004718. doi: 10.1002/14651858.CD004718.pub2.
3
Early intervention for psychosis.精神病的早期干预
Cochrane Database Syst Rev. 2011 Jun 15(6):CD004718. doi: 10.1002/14651858.CD004718.pub3.
4
The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.低强度心理干预在预防抑郁复发中的临床效果和成本效益:系统评价。
Health Technol Assess. 2012 May;16(28):1-130. doi: 10.3310/hta16280.
5
[Specialised first-episode psychosis services: a systematic review of the literature].[专科首发精神病服务:文献系统综述]
Encephale. 2011 May;37 Suppl 1:S66-76. doi: 10.1016/j.encep.2010.08.004. Epub 2010 Oct 12.
6
Antioxidant treatments for schizophrenia.精神分裂症的抗氧化治疗
Cochrane Database Syst Rev. 2016 Feb 5;2(2):CD008919. doi: 10.1002/14651858.CD008919.pub2.
7
Droperidol for psychosis-induced aggression or agitation.氟哌利多用于治疗精神病性激越或激惹。
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD002830. doi: 10.1002/14651858.CD002830.pub3.
8
Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.成人及儿童中与HIV感染相关的口腔念珠菌病的预防及管理干预措施。
Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003940. doi: 10.1002/14651858.CD003940.pub3.
9
Early Intervention for psychosis.精神病的早期干预
Cochrane Database Syst Rev. 2004(2):CD004718. doi: 10.1002/14651858.CD004718.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

引用本文的文献

1
Relapse rate and predictors among people with severe mental illnesses at Debre Markos Comprehensive specialized hospital, Northwest Ethiopia: a prospective follow up study.埃塞俄比亚西北部德布雷马尔科斯综合专科医院重度精神疾病患者的复发率及预测因素:一项前瞻性随访研究
Eur Arch Psychiatry Clin Neurosci. 2024 Sep 18. doi: 10.1007/s00406-024-01900-1.
2
Shanghai Community-Based Schizophrenia Cohort (SCS): a protocol for establishing a longitudinal cohort and research database of patients with schizophrenia receiving community-based mental health treatment.上海社区精神分裂症队列研究(SCS):一项建立社区精神卫生治疗的精神分裂症患者纵向队列和研究数据库的方案。
BMJ Open. 2024 Apr 9;14(4):e079312. doi: 10.1136/bmjopen-2023-079312.
3
Development and validation of a prediction model for rehospitalization among people with schizophrenia discharged from acute inpatient care.
急性住院治疗出院的精神分裂症患者再住院预测模型的开发与验证
Front Psychiatry. 2023 Aug 24;14:1242918. doi: 10.3389/fpsyt.2023.1242918. eCollection 2023.
4
Culturally adapted family intervention for people with schizophrenia in Indonesia (FUSION): a development and feasibility study protocol.印度尼西亚针对精神分裂症患者的文化适应性家庭干预(FUSION):一项开发与可行性研究方案
Pilot Feasibility Stud. 2023 Mar 30;9(1):53. doi: 10.1186/s40814-023-01280-8.
5
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse.绝经后精神分裂症谱系障碍女性:易复发的脆弱群体。
Schizophr Bull. 2023 Jan 3;49(1):136-143. doi: 10.1093/schbul/sbac139.
6
Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.数字化智能手机干预识别和管理精神分裂症早期预警信号以预防复发:EMPOWER 可行性聚类 RCT。
Health Technol Assess. 2022 May;26(27):1-174. doi: 10.3310/HLZE0479.
7
Identifying Modifiable Risk Factors for Relapse in Patients With Schizophrenia in China.识别中国精神分裂症患者复发的可改变风险因素。
Front Psychiatry. 2020 Sep 11;11:574763. doi: 10.3389/fpsyt.2020.574763. eCollection 2020.
8
Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.精神分裂症和分裂情感障碍的短信防复发 (T4RP) 研究的临床结果。
Psychiatry Res. 2020 Oct;292:113346. doi: 10.1016/j.psychres.2020.113346. Epub 2020 Jul 29.
9
Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support.早期症状监测以预防精神病复发并促进幸福感、参与度和康复:一项利用手机技术与同伴支持相结合的可行性整群随机对照试验方案
JMIR Res Protoc. 2020 Jan 9;9(1):e15058. doi: 10.2196/15058.
10
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections.比利时精神分裂症医疗途径的人类健康益处与负担:棕榈酸帕利哌酮长效注射剂
BMC Health Serv Res. 2019 Jun 19;19(1):393. doi: 10.1186/s12913-019-4247-2.